NCT01894685View on ClinicalTrials.gov

Mesalazine Effects in Sporadic Colorectal Adenoma Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Sporadic Colorectal Adenoma
Interventions
DRUG

Mesalazine

Mesalazine 3 grams, once daily for six months

DRUG

Placebo

Placebo 3 grams, once daily for six months

Trial Locations (1)

3584 CX

University Medical Center Utrecht, Utrecht

All Listed Sponsors
lead

UMC Utrecht

OTHER

NCT01894685 - Mesalazine Effects in Sporadic Colorectal Adenoma Patients | Biotech Hunter | Biotech Hunter